Description: The Group Life COVID-19 Mortality Survey gathers a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic through June 2023, as compared to prior period baseline mortality results. This new report is an update to the survey report released in May 2023, which contained data through December 2022.

Description: Summarizes the results of a follow-up survey of a panel of experts on COVID-19 to see how views on the disease’s impact on future U.S. mortality may have changed.

Description: Are you searching for an overview of the SOA Research Institute's Mortality & Longevity Strategic Research Program? Join us for an introduction into studies focusing on the historical U.S. population and insured mortality trends. Two research projects are observed in this webcast, one examining the impact of COVID-19 on mental illness and the impact of mental illness on U.S. Mortality & Longevity. The second study looks into the Group Life COVID-19 Mortality Survey and the high level view of U.S. group term life insurance mortality results during the pandemic. Come explore the research goals and the future for the Mortality & Longevity Strategic Program.

Description: LIMRA, Reinsurance Group of America (RGA), the Society of Actuaries (SOA) Research Institute, and TAI have collaborated on an ongoing effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience and share the emerging results with the insurance industry and the public. This report contains the results of a cause of death analysis focused on how the rates of death for various causes were impacted throughout the pandemic period through the second quarter of 2022.

Description: In this session, the latest research from the Society of Actuaries (SOA) Research Institute examining the impact of COVID-19 on mortality is highlighted. Included will be insights into how the life insured population is faring during COVID-19. Among the studies presented is an effort underway to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience. Additionally, the SOA Research Institute surveyed insurers to gather a high-level view of U.S. group term life insurance mortality results during the COVID-19 pandemic and comparing them to pre-pandemic mortality levels. By attending this session, you will:•Understand SOA Research Institute activities on COVID-19's influence on mortality•Apply research results and insights presented in daily work.

Description: This study quantifies the range of intercompany variability in mortality. Mean actual-to-expected (A/E) ratios based on amount were calculated in each quintile for every combination of six key variables.

Description: The most recent U.S. population data released by the Centers for Disease Control and Prevention (CDC) and from the U.S. Census at year-end 2021 includes the first ten months of the COVID-19 pandemic in the U.S. While we know the pandemic has had significant impacts on both the U.S. population and insured population mortality, we also see increased mortality due to many other non-COVID causes of death. Where are the biggest changes and what does this non-COVID excess mortality mean over the next few years? Take part as an expert panel hosts an interactive discussion to examine data from general population as well as from both individual life and group life experience studies to explore how these changes might spur innovation in underwriting, assumption setting and pricing.

Description: Through the sponsorship of the Robert Wood Johnson Foundation, The Society of Actuaries partnered with Wakely to use their health care data to study the effects of COVID-19 on overall health care claims for individuals with a COVID-19 diagnosis. The conclusion of the study is that individuals with COVID-19 claims had significant increases in health care costs leading up to their months of diagnosis, as well as in the months following their diagnosis. These effects were more pronounced for individuals who were hospitalized due to COVID-19 as well as for individuals with prior co-morbidities. Finally, the overall health care costs of these members plateaued at significantly higher levels than their pre-COVID baselines. In fact, all the main membership cohorts experienced claim levels that were at least 20% higher than their pre-COVID starting points.

Description: Research Sponsorship Opportunity: Post Pandemic Mortality by Generation

Description: An analysis of US population mortality trends and the impact of COVID.